2008
DOI: 10.1007/s10620-008-0296-9
|View full text |Cite
|
Sign up to set email alerts
|

The Expression of Hypoxia-Inducible Factor-1α in Hepatitis B Virus-Related Hepatocellular Carcinoma: Correlation with Patients’ Prognosis and Hepatitis B Virus X Protein

Abstract: Hypoxia inducible factor-1alpha (HIF-1alpha) was well correlated with carcinogenesis and tumor progression in many kinds of cancer. In this study, high expression of HIF-1alpha was found in 37 of the 72 (51.39%) tumor specimens, and significantly correlated with venous invasion and lymphonode invasion. Patients with high expression of HIF-1alpha had a significantly shorter overall survival rate and disease-free survival rate than those with low expression. Multivariate analysis showed high HIF-1alpha expressio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
59
0

Year Published

2009
2009
2013
2013

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 51 publications
(59 citation statements)
references
References 28 publications
0
59
0
Order By: Relevance
“…A general principle of targeted therapy is that patient selection is based on the demonstration that increased expression or activity of the target is associated with poor prognosis. Based on this reasoning, patients with HIF-1␣ overexpression demonstrated by immunohistochemistry on biopsy of cancers in which this phenotype is associated with increased mortality, such as prostate and hepatocellular carcinoma (8,9), may be particularly good candidates for inclusion of daily DXR or DNR in a treatment regimen. Clinical trials are warranted to test these hypotheses, and additional preclinical studies are needed to investigate the effects of daily anthracycline therapy on other aspects of cancer biology that are regulated by HIF-1, including tumor metabolism, invasion, and metastasis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A general principle of targeted therapy is that patient selection is based on the demonstration that increased expression or activity of the target is associated with poor prognosis. Based on this reasoning, patients with HIF-1␣ overexpression demonstrated by immunohistochemistry on biopsy of cancers in which this phenotype is associated with increased mortality, such as prostate and hepatocellular carcinoma (8,9), may be particularly good candidates for inclusion of daily DXR or DNR in a treatment regimen. Clinical trials are warranted to test these hypotheses, and additional preclinical studies are needed to investigate the effects of daily anthracycline therapy on other aspects of cancer biology that are regulated by HIF-1, including tumor metabolism, invasion, and metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…In prostate cancer patients treated with radiotherapy or radical prostatectomy, increased HIF-1␣ levels are associated with reduced time to disease progression (8). In hepatocellular carcinoma, increased HIF-1␣ levels are associated with venous and lymph node invasion and patient mortality (9).…”
mentioning
confidence: 99%
“…HCCs are known to overexpress both HIF-a-subunits correlating with poor patient prognosis. 5,16 Taking into account that HIF isoforms differentially regulate gene expression during tumor progression, an analysis of the specific functions of each subunit is needed. Therefore, we established HepG2 tumor spheroids deficient for HIF-1a, HIF2a, or HIF-1b as an HCC in vitro tumor model to elucidate cell death regulation.…”
Section: Discussionmentioning
confidence: 99%
“…Upregulated HIF-1α in HCC is correlated well with portal vein invasion, lymph node metastasis, and is an adverse prognostic factor for HCC patients [Xie et al, 2008].…”
Section: Hbx Regulation Of Ca IX Expression In Human Hepatocellular Cmentioning
confidence: 99%